Merck Expands Protein A Capabilities with JSR Chromatography Acquisition
The company says the acquisition will strengthen downstream antibody manufacturing and help biopharma customers scale more efficiently.
False
The company says the acquisition will strengthen downstream antibody manufacturing and help biopharma customers scale more efficiently.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 16, 2026
1 min read
Nucleome Therapeutics CTO Jonny Wray reveals how an engineer’s mindset can help navigate the complexity of human biology
October 12, 2026
2 min read
“Caribou’s story has taken a heartbreaking turn,” says CEO Rachel Haurwitz, with the CRISPR-focused biotech set to discontinue vispa-cel and CB-011, and reduce its workforce
October 12, 2026
5 min read
Bayer plans a $2.2 billion Ohio campus, Genentech breaks ground in Oregon, and new investments support vaccine production, downstream processing, and manufacturing in orbit
October 8, 2026
2 min read
Adicet Bio reports 12-month remission and renal response data for its allogeneic gamma delta CAR T therapy
False
Affiliations:
Specialties:
Areas of Expertise: